Chinese Medical Journal (Mar 2021)
Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
Abstract
No abstracts available.
Chinese Medical Journal (Mar 2021)